Kia Cameron, Baldino Joshua, Bell Ryan, Ramji Alim, Uyeki Colin, Mazzocca Augustus
University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT, USA.
Curr Rev Musculoskelet Med. 2018 Dec;11(4):566-572. doi: 10.1007/s12178-018-9515-y.
Platelet-rich plasma (PRP) contains numerous growth factors and cytokines that potentially offer an alternative treatment modality to assist in the healing of multiple musculoskeletal issues. The purpose of this review was to examine the latest literature on the use of PRP for various ligament and tendon pathologies.
Recent literature has shown moderate- to high-quality evidence that PRP can have positive clinical effects in certain conditions such as lateral epicondylitis and rotator cuff tendinopathy. Prospective studies have shown that it can also be useful in the treatment of patella tendinopathy. In summary, we found PRP to have variable success in ligament and tendon pathology; however, it should be considered a viable option in chronic musculoskeletal disease that has failed other treatments. Patient selection, duration of symptoms, and combining with other modalities such as physical therapy should all be taken into consideration in treatment with PRP.
富含血小板血浆(PRP)含有多种生长因子和细胞因子,可能提供一种替代治疗方式,以协助多种肌肉骨骼问题的愈合。本综述的目的是研究关于PRP用于各种韧带和肌腱病变的最新文献。
近期文献显示了中等至高质量的证据,表明PRP在某些情况下,如外侧上髁炎和肩袖肌腱病,可产生积极的临床效果。前瞻性研究表明,它在髌腱病的治疗中也可能有用。总之,我们发现PRP在韧带和肌腱病变中的成功率各不相同;然而,在其他治疗失败的慢性肌肉骨骼疾病中,它应被视为一种可行的选择。在使用PRP进行治疗时,应考虑患者选择、症状持续时间以及与物理治疗等其他方式相结合。